About Actafarma
Actafarma is a Healthcare company based in Madrid (Spain) founded in 1997, and was acquired by Kern Pharma in April 2017. Pharmaceutical drugs for health, mobility, and beauty are manufactured. Actafarma offers products and services including Dolostop Plus, ENDOLEX, OXICOL, and REDIGEST PRO. Its focus areas include Diversified Pharmaceuticals. Its legal entity is KERN PHARMA, S.L.
Company details
Actafarma was founded in 1997 and is based in Madrid, Spain. Operations focus on the manufacturing of pharmaceutical drugs within the healthcare sector. Products are developed to address needs in health, mobility, and beauty, among other areas. The company maintains its primary activities in Spain, with distribution likely extending to regional markets through established pharmaceutical channels.
- Headquarters Madrid, Spain
- Stage Acquired
- SectorsHealthcare
- Website actafarma.com
- Social LinkedIn X Facebook Instagram YouTube
- Acquired by Kern Pharma (Apr 2017)
- Legal Name Kern Pharma, S.L.
- Investors
- Acquired byKern Pharma
(Apr 2017)
Products & Services of Actafarma
Actafarma offers a comprehensive portfolio of products and services, including Dolostop Plus, ENDOLEX, OXICOL, and REDIGEST PRO.
Treats mild to moderate pain in adults through oral medication.
Alleviates acute muscular, joint, menstrual, or dental pain.
Supports heart function and maintains cholesterol levels effectively.
Improves digestion, reduces gas, and aids lactose breakdown.
Apps and channels of Actafarma
its YouTube channel Kern Pharma has 1.12K subscribers and 30 videos.
Videos from Actafarma
The most watched videos on Actafarma's YouTube channel, Kern Pharma (1.12K subscribers). Click a video to play it here.
More on Kern Pharma.
Investors in Actafarma
Actafarma has secured backing from 1 investor. Prominent investors backing the company include Kern Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Kern Pharma is engaged in developing and marketing pharmaceuticals. | kernpharma.com | Terrassa, Spain |
Investor details for Actafarma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Actafarma
2 dated milestones of Actafarma across 20 years, from founding to its latest funding, stage changes and deals.
- Founded Actafarma is founded.
- Exit Acquired by Kern Pharma.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Actafarma
Actafarma was founded in 1997.
Actafarma is headquartered in Madrid, Spain. It is registered at Madrid, Madrid, Spain.
Actafarma was founded in 1997 and is based in Madrid, Spain. Operations focus on the manufacturing of pharmaceutical drugs within the healthcare sector. Products are developed to address needs in health, mobility, and beauty, among other areas. The company maintains its primary activities in Spain, with distribution likely extending to regional markets through established pharmaceutical channels.
Actafarma offers Dolostop Plus, ENDOLEX, OXICOL, and REDIGEST PRO.
Actafarma has 1 investor. Key investors include Kern Pharma.
Actafarma operates through Kern Pharma, S.L..
Yes. Actafarma was acquired by Kern Pharma in April 2017.